An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

SIMPLE SUMMARY: Treatment of patients diagnosed with advanced pulmonary adenocarcinoma depends on the presence of genomic aberrations that are targetable for a specific tyrosine kinase inhibitor. Subsequent treatment lines depend on presence of mutations that are associated with emerging resistance....

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jiacong, Rybczynska, Anna A., Meng, Pei, Terpstra, Martijn, Saber, Ali, Sietzema, Jantine, Timens, Wim, Schuuring, Ed, Hiltermann, T. Jeroen N., Groen, Harry J. M., van der Wekken, Anthonie J., van den Berg, Anke, Kok, Klaas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650834/
https://www.ncbi.nlm.nih.gov/pubmed/33019710
http://dx.doi.org/10.3390/cancers12102843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650834/
https://www.ncbi.nlm.nih.gov/pubmed/33019710
http://dx.doi.org/10.3390/cancers12102843

Ejemplares similares